Effect of Crocus sativus L. (Saffron) on Selected Cardiometabolic Traits in Healthy Young Men
Abstract
No abstract
1. Termentzi A. Kokkalou, E (2008).LC-DAD-MS (ESI+) analysis and antioxidant ca-pacity of Crocus sativus petal extracts. Planta Medica, 74:573–581. doi: 10.1055/s2008-1074498.
2. Moshiri M, Vahabzadeh M, Hosseinzadeh H (2015). Clinical Applications of Saffron (Crocus sativus) and its Constituents: A Re-view. Drug Research (Stuttg), 65(6): 287-295. doi: 10.1055/s-0034-1375681.
3. Javandoost A, Afshari A, Nikbakht-Jam I, et al (2017). Effect of crocin, a carotenoid from saffron, on plasma cholesteryl ester transfer protein and lipid profile in sub-jects with metabolic syndrome: A double blind randomized clinical trial. ARYA Atheroscler, 13(5):245-252.
4. Ebrahimi F, Aryaeian N, Heydari I (2019). The Effect of Saffron (Crocus sativus L.) Supplementation on Blood Pressure, and Renal and Liver Function in Patients With Type 2 Diabetes Mellitus: A Double-Blinded, Randomized Clinical Trial. Avi-cenna J Phytomed,9 (4):322-333.
5. BathaieSZ, MousaviSZ (2010). New applica-tions and mechanisms of action of saf-fron and its important ingredients. Crit Rev Food Sci Nutr, 50(8):761–768.
6. Modaghegh MH, Shahabian M, Esmaeili HA, Rajbai O, Hosseinzadeh H (2008). Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. J Phymed, 15:1032–1037.
7. Imenshahidi M, Razavi BM, Faal A, Gholampoor A, Mousavi SM, Hosse-inzadeh H (2013).The Effect of Chronic Administration of Saffron (Crocus sativus) Stigma Aqueous Extract on Systolic Blood Pressure in Rats. Jundishapur J Nat Pharm Prod, 8(4): 175–179.
8. SamarghandianS, AfshariR, Sadati A (2014). Evaluation of lung and bronchoalveolar lavage fluid oxidative stress indices for assessing the preventing effects of safra-nal on respiratory distress in diabetic rats. Scientific World Journal, 2014:251378. doi: 10.1155/2014/251378.
9. Milajerdi A, Djazayeri A, Jazayeri S, et al (2016). The effect of hydroalcoholic ex-tract of saffron stigma (Crocus Sativus L.) on metabolic control parameters, liver enzymes, and renal function parameters in type 2 diabetic patients. J Med Plants, 4(60): 142-151.
10. Farkhondeh T, Samarghandian S (2014).The effect of saffron (Crocus sativus L.) and its ingredients on the management of diabe-tes mellitus and dislipidemia. Afr J PharmPharmacol, 8:541–549.
2. Moshiri M, Vahabzadeh M, Hosseinzadeh H (2015). Clinical Applications of Saffron (Crocus sativus) and its Constituents: A Re-view. Drug Research (Stuttg), 65(6): 287-295. doi: 10.1055/s-0034-1375681.
3. Javandoost A, Afshari A, Nikbakht-Jam I, et al (2017). Effect of crocin, a carotenoid from saffron, on plasma cholesteryl ester transfer protein and lipid profile in sub-jects with metabolic syndrome: A double blind randomized clinical trial. ARYA Atheroscler, 13(5):245-252.
4. Ebrahimi F, Aryaeian N, Heydari I (2019). The Effect of Saffron (Crocus sativus L.) Supplementation on Blood Pressure, and Renal and Liver Function in Patients With Type 2 Diabetes Mellitus: A Double-Blinded, Randomized Clinical Trial. Avi-cenna J Phytomed,9 (4):322-333.
5. BathaieSZ, MousaviSZ (2010). New applica-tions and mechanisms of action of saf-fron and its important ingredients. Crit Rev Food Sci Nutr, 50(8):761–768.
6. Modaghegh MH, Shahabian M, Esmaeili HA, Rajbai O, Hosseinzadeh H (2008). Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. J Phymed, 15:1032–1037.
7. Imenshahidi M, Razavi BM, Faal A, Gholampoor A, Mousavi SM, Hosse-inzadeh H (2013).The Effect of Chronic Administration of Saffron (Crocus sativus) Stigma Aqueous Extract on Systolic Blood Pressure in Rats. Jundishapur J Nat Pharm Prod, 8(4): 175–179.
8. SamarghandianS, AfshariR, Sadati A (2014). Evaluation of lung and bronchoalveolar lavage fluid oxidative stress indices for assessing the preventing effects of safra-nal on respiratory distress in diabetic rats. Scientific World Journal, 2014:251378. doi: 10.1155/2014/251378.
9. Milajerdi A, Djazayeri A, Jazayeri S, et al (2016). The effect of hydroalcoholic ex-tract of saffron stigma (Crocus Sativus L.) on metabolic control parameters, liver enzymes, and renal function parameters in type 2 diabetic patients. J Med Plants, 4(60): 142-151.
10. Farkhondeh T, Samarghandian S (2014).The effect of saffron (Crocus sativus L.) and its ingredients on the management of diabe-tes mellitus and dislipidemia. Afr J PharmPharmacol, 8:541–549.
Files | ||
Issue | Vol 51 No 7 (2022) | |
Section | Letter to the Editor | |
DOI | https://doi.org/10.18502/ijph.v51i7.10103 |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Abassi W, Ouerghi N, Jebabli N, Feki M, Bouassida A. Effect of Crocus sativus L. (Saffron) on Selected Cardiometabolic Traits in Healthy Young Men. Iran J Public Health. 2022;51(7):1679-1680.